Allon Therapeutics Report issue

For profit Phase 3
Founded: Vancouver BC Canada (2001)
Status: Acquired by Paladin Labs (2013) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
2006
NCT00404014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Medical Monitor on behalf of Allon Therapeutics

Active Ingredients

Drugs in Phase 3 Trials (1)

davunetide (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 2)

Supranuclear Palsy, Progressive (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1